Related Experiment Videos
[Infections in solid organ transplant recipients]
Jennifer Cuellar-Rodríguez1, Juan G Sierra-Madero
1Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF.
Summary
Infection remains a major threat to solid organ transplant recipients, impacting survival and quality of life. Early detection and clinical experience are crucial for managing these post-transplant infectious diseases.
Area of Science:
- Transplant medicine
- Infectious diseases
- Immunology
Background:
- Solid organ transplant recipients face significant risks of rejection and infection.
- While immunosuppressive therapies reduce rejection, infections remain a leading cause of morbidity and mortality.
- Infectious complications significantly impact graft survival and patient outcomes.
Purpose of the Study:
- To review current information on infectious diseases in solid organ transplant recipients.
- To analyze infections based on transplant type, post-transplant period, and risk factors.
- To highlight the importance of clinical expertise in managing post-transplant infections.
Main Methods:
- Review of recent literature on infectious diseases in solid organ transplant recipients.
- Categorization of infections by origin (viral, bacterial, fungal, parasitic).
- Analysis of risk factors including transplant type, immunosuppressive therapy, and pre-transplant conditions.
Main Results:
- Infections are a primary cause of mortality and morbidity in transplant patients.
- Infections present characteristically within defined post-transplant periods but often atypically.
- Prognosis is influenced by infection type, timing, and patient-specific risk factors.
Conclusions:
- Understanding the epidemiology and clinical manifestations of post-transplant infections is essential.
- Clinician experience in early detection and management is critical for improving outcomes.
- Tailoring management based on transplant type and immunosuppression is key to mitigating infectious risks.